Output

Publications

Ogura K, Elkrief A, Bowman AS, Koche RP, de Stanchina E, Benayed R, Mauguen A, Mattar MS, Khodos I, Meyers PA, Healey JH, Tap WD, Hameed M, Zehir A, Shukla N, Sawyers C, Bose R, Slotkin E, Ladanyi M. Prospective Clinical Genomic Profiling of Ewing Sarcoma: ERF and FGFR1 Mutations as Recurrent Secondary Alterations of Potential Biologic and Therapeutic Relevance. JCO Precision Oncology. (2022)

Dr. Martin Sjöström , Dr. Shuang G. Zhao , Dr. Samuel Levy , Dr. Meng Zhang , Dr. Yuhong Ning , Dr. Raunak Shrestha , Dr. Arian Lundberg , Mr. Cameron Herberts , Mr. Adam Foye , Dr. Rahul R. Aggarwal , Dr. Junjie T. Hua , Dr. Haolong Li , Dr. Anna Bergamaschi , Dr. Corinne Maurice-Dror , Mr. Ashutosh Maheshwari , Sujun Chen , Ms. Sarah W. Ng , Dr. Wenbin Ye , Jessica Petricca , Dr. Michael Fraser , Dr. Lisa Chesner , Dr. Marc D. Perry , Dr. Thaidy Moreno-Rodriguez , Mr. William S. Chen , Dr. Joshi J. Alumkal , Dr. Jonathan Chou , Dr. Alicia K. Morgans , Dr. Tomasz M. Beer , Dr. George V. Thomas , Dr. Martin Gleave , Paul Lloyd , Ms. Tierney Phillips , Ms. Erin McCarthy , Dr. Michael C. Haffner , Dr. Amina Zoubeidi , Mr. Matti Annala , Dr. Rob E. Reiter , Dr. Matthew B. Rettig , Dr. Owen N. Witte , Dr. Lawrence Fong , Dr. Rohit Bose , Dr. Franklin W. Huang , Dr. Jianhua Luo , Dr. Anders Bjartell , Dr. Joshua M. Lang , Dr. Nupam P. Mahajan , Dr. Primo N. Lara , Dr. Christopher P. Evans , Dr. Phuoc T. Tran , Dr. Edwin M. Posadas , Dr. Chuan He , Dr. Xiaolong Cui , Dr. Jiaoti Huang , Dr. Wilbert Zwart , Dr. Luke A. Gilbert , Dr. Christopher A. Maher , Dr. Paul C. Boutros , Dr. Kim N. Chi , Dr. Alan Ashworth , Dr. Eric J. Small , Dr. Housheng H. He , Dr. Alexander W. Wyatt , Dr. David A. Quigley. The 5-hydroxymethylcytosine landscape of prostate cancer. Accepted at Cancer Research (2022).

Kwon DH, Karthikeyan S, Chang A, Borno HT, Koshkin VS, Desai A, Bose R, Friedlander T, Rodvelt T, Li P, Small EJ, Aggarwal RR, Belkora J. Mobile Audio Recording Technology to Promote Informed Decision Making in Advanced Prostate Cancer. JCO Oncology Practice. (2021)

Zhao SG, Chen WS, Li H, Foye A, Zhang M, Sjöström M, Aggarwal R, Playdle D, Liao A, Alumkal JJ, Das R, Chou J, Hua JT, Barnard TJ, Bailey AM, Chow ED, Perry MD, Dang HX, Yang R, Moussavi-Baygi R, Zhang L, Alshalalfa M, Laura Chang S, Houlahan KE, Shiah YJ, Beer TM, Thomas G, Chi KN, Gleave M, Zoubeidi A, Reiter RE, Rettig MB, Witte O, Yvonne Kim M, Fong L, Spratt DE, Morgan TM, Bose R, Huang FW, Li H, Chesner L, Shenoy T, Goodarzi H, Asangani IA, Sandhu S, Lang JM, Mahajan NP, Lara PN, Evans CP, Febbo P, Batzoglou S, Knudsen KE, He HH, Huang J, Zwart W, Costello JF, Luo J, Tomlins SA, Wyatt AW, Dehm SM, Ashworth A, Gilbert LA, Boutros PC, Farh K, Chinnaiyan AM, Maher CA, Small EJ, Quigley DA, Feng FY. The DNA methylation landscape of advanced prostate cancer. Nature Genetics. (2020)

Ryan M, Bose R. Genomic Alteration Burden in Advanced Prostate Cancer and Therapeutic Implications. Front Oncol. (2019)

Adams E, Karthaus W, Hoover E, Liu D, Gruet A, Zhang Z,Cho H, DiLoreto R, Chhangawala S, DiLoreto R, Liu Y, Watson P, Davicioni E, Sboner A, Barberi C, Bose R, Leslie C, Sawyers C. FOXA1 mutations alter pioneering activity, differentiation, and prostate cancer phenotypes. Nature, (2019).

Bose R, Karthaus W, Armenia J, Abida W, Iaquinta P, Wongvipat J, Wasmuth E, Shah N, Doran M, Wang P, Sullivan P, Patruno A, International SU2C/PCF Prostate Cancer Dream Team, Zheng D, Schultz N, Sawyers C. ERF mutations reveal balance of positive and negative ETS factors controlling prostate cancer. Nature, 546, pp. 671-675 (2017).

Highlighted in:

ERF Competes with ERG for Chromatin Binding to Control Oncogenesis. Cancer Discov. (2017)
Thoma C. Prostate cancer: ETS factors in the balance. Nat Rev Urol. 14, p. 454 (2017).
Atala A. Re: ERF Mutations Reveal a Balance of ETS Factors Controlling Prostate Oncogenesis. J Urol. 200 (2018).
F1000 Recommendation. F1000Prime. (2017).

Kelly W, Godwin J, Hoffman-Censits J, Knudsen K, De Leeuw R, Leiby B, Southwell T, Hubert C, Smith D, Chatta G, Agahalar J, Scher H, Bose R, Autio K, Abida W, Slovin S, The Prostate Cancer Clinical Trials Consortium. c15-153: Randomized phase IB/II study of enzalutamide with and without ribociclib in patients with metastatic castrate resistant, chemotherapy naïve prostate cancer that retains RB expression. Journal of Clinical Oncology. 20 (2018).

Silvestri C, Bose R, Attisano L and Wrana J. Functioning of Transmembrane Receptors in Signaling Mechanisms: Cell Signaling Collection, TGF β Signal Transduction. 70, pp. 521-532 (2010).

Bose R*, Narimatsu M*, Pye M, Zhang L, Miller B, Ching P, Sakuma, R, Luga V, Roncari L, Attisano L, Wrana J. Regulation of planar cell polarity by Smurf ubiquitin ligases. Cell, 137, pp. 295-307 (2009). *co-first authors.

Highlighted in:

Mlodzik M. Ubiquitin connects with planar cell polarity. Cell. 137, 209 (2009).
Wong W. Smurfed Up PCP. Sci. Signal. 2, 148 (2009).
Keeley J. Smurf Genes Help Cells Find Path Ahead. HHMI (2009).
F1000 Recommendation. F1000Prime. (2009).

Viloria-Petit A, David L, Jia J, Erdemir T, Bane A, Pinnaduwage D, Roncari L, Narimatsu M, Bose R, Moffat J, Wong J, Kerbel R, O'Malley F, Andrulis I, Wrana J. A role for the TGFβ-Par6 polarity pathway in breast cancer progression. Proc Natl Acad Sci USA, 106, pp.14028-14033 (2009).

Wang H, Ogunjimi A, Zhang Y, Ozdamar B, Bose R and Wrana, J. Degradation of RhoA by Smurf1 ubiquitin ligase. Methods in enzymology, 406, pp.437-447 (2006).

Le Roy C, Bose R and Wrana J. Trafficking of Serine/Threonine Kinase Receptors and Smad Activation. Smad Signal Transduction. 9, pp. 177-191 (2006).

Bose R*, Ozdamar B*, Barrios-Rodiles M, Wang H, Zhang Y and Wrana J. Regulation of the polarity protein Par6 by TGFß receptors controls epithelial cell plasticity. Science, 307, pp.1603-1609 (2005). *co-first authors.

Highlighted in:

Thiery, JP, Huang R. Linking Epithelial-Mesenchymal Transition to the Well-Known Polarity Protein Par6. Dev Cell. 8, p. 456 (2005).
Bussell, K. Undoing tight junctions. Nature Rev Mol Cell Biol. 6, 358 (2005).
Eisenstein, M. Everything is illuminated. Nature Methods. 2, p. 323 (2005).
Unraveling Signaling Networks. Science STKE. (2005).
F1000 Recommendation. F1000Prime. (2005).

Barrios-Rodiles M, Brown K, Ozdamar B, Bose R, Liu Z, Donovan R, Shinjo F, Liu Y, Dembowy J, Taylor I,Luga V, Przulj N, Robinson M, Suzuki H, Hayashizaki Y, Jurisica I, Wrana J. High-throughput mapping of a dynamic signaling network in mammalian cells. Science, 307, pp.1621-1625 (2005).

Highlighted in: